Lastly, MTORT1 may serve as sponge of miR-26a-5p to up-regulate its target genes, CREB1 and STK4. These data suggest that MTORT1 may be a candidate for developing novel therapeutic regimen to inhibit breast cancer progression. This evidence concerns the gene CREB1 and breast cancer.